Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019: A Population-based Study

Mohamed Attauabi*, Jens Frederik Dahlerup, Anja Poulsen, Malte Rosager Hansen, Marianne Kajbæk Vester-Andersen, August Pilegaard Prahm, Natalia Pedersen, Lone Larsen, Tine Jess, Anders Neumann, Kent V Haderslev, Akbar Molazahi, Anders Berg Lødrup, Henning Glerup, Asser Mathiassen Oppfeldt, Michael Dam Jensen, Klaus Theede, Marianne Kiszka-Kanowitz, Jakob Benedict Seidelin, Johan BurischThe Danish COVID-IBD Study Group, Torben Knudsen (Member of author group), Torben Nathan (Member of author group)

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

This brief report investigated the impact of clinical, biochemical, and endoscopic activity of IBD on the severity and long-term outcomes of COVID-19 in a prospective population-based cohort. The study did not identify any association between IBD activity and COVID-19 outcomes.

Original languageEnglish
JournalInflammatory Bowel Diseases
Volume28
Issue number10
Pages (from-to)1618-1622
ISSN1078-0998
DOIs
Publication statusPublished - 3. Oct 2022

Keywords

  • COVID-19/epidemiology
  • Humans
  • Inflammatory Bowel Diseases
  • SARS-CoV-2
  • sequelae
  • inflammatory bowel diseases
  • COVID-19 outcomes
  • disease activity
  • population-based

Fingerprint

Dive into the research topics of 'Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019: A Population-based Study'. Together they form a unique fingerprint.

Cite this